Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01772667|
Recruitment Status : Completed
First Posted : January 21, 2013
Last Update Posted : November 23, 2016
|Condition or disease||Intervention/treatment||Phase|
|Idiopathic Pulmonary Fibrosis||Procedure: Inpatient Rehabilitation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||51 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Long Term Effects of a 3-week Inpatient Pulmonary Rehabilitation Program in Patients With Idiopathic Pulmonary Fibrosis|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||June 2016|
|Actual Study Completion Date :||October 2016|
No Intervention: Usual care
Usual care during the whole study period without pulmonary rehabilitation. The patients will perform their normal daily life.
Active Comparator: Inpatient Rehabilitation
3-week inpatient multimodal pulmonary rehabilitation program, including daily exercise training, breathing therapy, medical treatment and psychological support. In the following 3 month, the patients will perform their normal daily life.
Procedure: Inpatient Rehabilitation
Rehabilitation program in "Schoen Klinik Berchtesgadener Land"
- Delta of 6-minute walking distance from 1 week pre rehabilitation to 3 month post rehabilitation [ Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation ]
- Delta of physical activity level from 1 week pre rehabilitation to 3 month post rehabilitation [ Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation ]
- Delta of SF36-score (questionnaire to measure quality of life) from 1 week pre to 3 month post rehabilitation [ Time Frame: 1 week before rehabilitation to 3 month after finishing rehabilitation ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01772667
|Schoen Klinik Berchtesgadener Land|
|Schoenau am Koenigssee, Bavaria, Germany, 83471|
|Study Director:||Klaus Kenn, MD||Head physician in the department of pulmology|